Biosynex

Biosynex

Manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market.

HQ location
Illkirch, France
Website
biosynex.com
Launch date
Employees
51-200 people
Market cap
$24.3m
Enterprise value
$82m
Share price
€1.21 ALBIO.PA
Company register number
481075703
Recent deals
https://twitter.com/seb_poirothttps://www.linkedin.com/company/biosynex-group
    • Edit
loading funding rounds…
Naxicap Partners
Naxicap Partners(exited)
Theradiag Group/Prestizia
Theradiag Group/Prestizia

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth-14 %350 %149 %(49 %)(53 %)9 %
EBITDA0000000000000000000000000000
% EBITDA margin3 %5 %34 %39 %32 %1 %2 %
Profit0000000000000000000000000000
% profit margin-3 %20 %27 %8 %(40 %)(43 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Biosynex

Edit
Theradiag Group/Prestizia
Theradiag Group/Prestizia
Chembio Diagnostic Systems
Chembio Diagnostic Systems
ACQUISITION by Biosynex Jan 2023
Dectra Pharm
Dectra Pharm
ACQUISITION by Biosynex Dec 2016
Fumouze Diagnostics
Fumouze Diagnostics
ACQUISITION by Biosynex May 2016
SR2B SA
SR2B SA
ACQUISITION by Biosynex Jul 2017
ProciseDx
ProciseDx
ACQUISITION by Biosynex Jun 2023
AVALUN
AVALUN
ACQUISITION by Biosynex May 2021